https://health.economictimes.indiatimes.com/news/pharma/usfda-cautions-aurobindo-pharmas-oral-solids-formulation-facility-of-regulatory-action/73785886
USFDA cautions Aurobindo Pharma's oral solids formulation facility of regulatory action,...
Aurobindo Pharma: According to USFDA's definitions, OAI means "objectionable conditions were found and regulatory administrative sanctions by FDA are...
aurobindo pharmaoral solids